These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2537398)
1. Use of synthetic oligopeptides in identification and characterization of immunological functions in the amino acid sequence of the envelope protein of HIV-1. Modrow S; Höflacher B; Mellert W; Erfle V; Wahren B; Wolf H J Acquir Immune Defic Syndr (1988); 1989; 2(1):21-7. PubMed ID: 2537398 [TBL] [Abstract][Full Text] [Related]
2. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1. Norrby E; Putkonen P; Böttiger B; Utter G; Biberfeld G AIDS Res Hum Retroviruses; 1991 Mar; 7(3):279-85. PubMed ID: 1712215 [TBL] [Abstract][Full Text] [Related]
3. Cellular immune response to viral peptides in patients exposed to HIV. Ahearne PM; Matthews TJ; Lyerly HK; White GC; Bolognesi DP; Weinhold KJ AIDS Res Hum Retroviruses; 1988 Aug; 4(4):259-67. PubMed ID: 2462895 [TBL] [Abstract][Full Text] [Related]
4. Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein. Chiodi F; von Gegerfeldt A; Albert J; Fenyö EM; Gaines H; von Sydow M; Biberfeld G; Parks E; Norrby E J Med Virol; 1987 Sep; 23(1):1-9. PubMed ID: 3500271 [TBL] [Abstract][Full Text] [Related]
5. Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection. Shafferman A; Lennox J; Grosfeld H; Sadoff J; Redfield RR; Burke DS AIDS Res Hum Retroviruses; 1989 Feb; 5(1):33-9. PubMed ID: 2541748 [TBL] [Abstract][Full Text] [Related]
6. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528 [TBL] [Abstract][Full Text] [Related]
7. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera. Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754 [TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV. Evans LA; Thomson-Honnebier G; Steimer K; Paoletti E; Perkus ME; Hollander H; Levy JA AIDS; 1989 May; 3(5):273-6. PubMed ID: 2548535 [TBL] [Abstract][Full Text] [Related]
9. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. Klasse PJ; Pipkorn R; Blomberg J Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899 [TBL] [Abstract][Full Text] [Related]
10. Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160. Berman PW; Riddle L; Nakamura G; Haffar OK; Nunes WM; Skehel P; Byrn R; Groopman J; Matthews T; Gregory T J Virol; 1989 Aug; 63(8):3489-98. PubMed ID: 2545918 [TBL] [Abstract][Full Text] [Related]
11. Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity. Meloen RH; Liskamp RM; Goudsmit J J Gen Virol; 1989 Jun; 70 ( Pt 6)():1505-12. PubMed ID: 2471813 [TBL] [Abstract][Full Text] [Related]
12. IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection. Chiodi F; Mathiesen T; Albert J; Parks E; Norrby E; Wahren B J Immunol; 1989 Jun; 142(11):3809-14. PubMed ID: 2497181 [TBL] [Abstract][Full Text] [Related]
13. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein. Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436 [TBL] [Abstract][Full Text] [Related]
14. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes. Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334 [TBL] [Abstract][Full Text] [Related]
15. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides. Neurath AR; Strick N; Lee ES J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372 [TBL] [Abstract][Full Text] [Related]
16. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Ho DD; Kaplan JC; Rackauskas IE; Gurney ME Science; 1988 Feb; 239(4843):1021-3. PubMed ID: 2830667 [TBL] [Abstract][Full Text] [Related]
17. A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations. Felser JM; Klimkait T; Silver J Virology; 1989 Jun; 170(2):566-70. PubMed ID: 2543131 [TBL] [Abstract][Full Text] [Related]
18. Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24. Schmidt G; Amiraian K; Frey H; Wethers J; Stevens RW; Berns DS J Clin Microbiol; 1989 May; 27(5):843-8. PubMed ID: 2501350 [TBL] [Abstract][Full Text] [Related]